Leeds, United Kingdom
NIQS Tech, founded in 2022, is a promising player in the Health Care and Medical Devices sectors, headquartered in the United Kingdom. Their mission is encapsulated by their slogan: “Glucose Insights, Smarter Living.” With a focus on health consciousness and wellness, NIQS Tech addresses the significant gap in the market for non-invasive, user-friendly glucose monitoring technologies.
The company stands out by introducing GlucoGlass, a patented innovation featuring quantum optical coupling that allows non-invasive glucose tracking directly from the wrist. The technology has demonstrated an impressive 99.8% accuracy in clinical studies, marking it as a potential game-changer in managing obesity and Type-2 diabetes through real-time data insights.
Having recently secured a £100.00K seed investment from SFC Capital as of 01 March 2024, NIQS Tech is well-positioned to further develop and scale their pioneering device, catering to the rising demand for advanced and accessible health monitoring solutions.
